SCHEMBL4235282

SCHEMBL4235282

COc1ccccc1CNC(=O)c1cccc2nc(C(N)=O)[nH]c12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.58
ALDH1A1 P00352 6/20 0.57
KDM4E B2RXH2 2/20 0.57
RCE1 Q9Y256 1/20 0.57
KMT2A Q03164 2/20 0.53
MEN1 O00255 1/20 0.53
ADORA1 P30542 1/20 0.50
LMNA P02545 1/20 0.50
MAPT P10636 1/20 0.50
GAA P10253 1/20 0.49
PKM P14618 1/20 0.49
HTT P42858 1/20 0.49
TDP1 Q9NUW8 1/20 0.48
NPC1 O15118 1/20 0.48
UBE2I P63279 1/20 0.48
CACNA1B Q00975 1/20 0.48
APBA1 Q02410 1/20 0.48
SAE1 Q9UBE0 1/20 0.48
UBA2 Q9UBT2 1/20 0.48
PLA2G1B P04054 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4241706 0.90 TP53 (0.49) HPGDALDH1A1KDM4ERCE1KMT2A
SCHEMBL4235288 0.87 HPGD (0.62) HPGDALDH1A1KDM4ERCE1KMT2A
SCHEMBL4239186 0.82 HPGD (0.50) HPGDALDH1A1KMT2AMEN1LMNA
SCHEMBL4239959 0.81 SMN1; SMN2 (0.53) HPGDKMT2ALMNAMAPTGAA
SCHEMBL4246321 0.80 HPGD (0.58) HPGDALDH1A1KDM4EKMT2A
SCHEMBL4241525 0.80 PARP1 (0.41) HPGDKMT2AMAPT
SCHEMBL4239339 0.78 HPGD (0.52) HPGDALDH1A1KDM4EKMT2AADORA1
SCHEMBL4246314 0.78 SMN1; SMN2 (0.50) ALDH1A1KDM4EKMT2ALMNAMAPT
SCHEMBL4440945 0.78 HPGD (0.63) HPGDALDH1A1KDM4ERCE1KMT2A
SCHEMBL4241708 0.77 TP53 (0.51) HPGDALDH1A1KDM4ERCE1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946259-B2 Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors HIGH POINT PHARMACEUTICALS, LLC (US) 2015-02-03 US disclosed
US-20140066477-A1 Benzazole Derivatives, Compositions, and Methods of Use as Beta-Secretase Inhibitors HIGH POINT PHARMACEUTICALS, LLC (US) 2014-03-06 US disclosed
US-8598353-B2 Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors HIGH POINT PHARMACEUTICALS, LLC (US) 2013-12-03 US disclosed
EP-2457901-A1 Benzazole derivatives, compositions, and methods of use as B-secretase inhibitors High Point Pharmaceuticals, LLC (US) 2012-05-30 EP disclosed
US-20090326006-A1 Benzazole Derivatives, Compositions, and Methods of Use as Beta-Secretase Inhibitors VTVX HOLDINGS II LLC 2009-12-31 US disclosed
US-20060223849-A1 Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors HIGH POINT PHARMACEUTICALS, LLC 2006-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326006-A1 Benzazole Derivatives, Compositions, and Methods of Use as Beta-Secretase Inhibitors BACE1, BACE2, APP HPGD 1702/4885ALDH1A1 1717/4885KDM4E 3510/4885
US-20060223849-A1 Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors BACE1, BACE2, APP HPGD 1702/4885ALDH1A1 1717/4885KDM4E 3510/4885
US-20140066477-A1 Benzazole Derivatives, Compositions, and Methods of Use as Beta-Secretase Inhibitors BACE1, BACE2, APP HPGD 1702/4885ALDH1A1 1717/4885KDM4E 3510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.